Dr. Hannon received his Ph.D. from Trinity College Dublin in 2020 where he developed and tested cancer nanomedicines. He is currently undergoing postdoctoral training at the University of Rochester Medical Center where he investigates the immunological effects of radiation and how they can be leveraged to enhance the effects of combination therapies.
Gary Hannon
